Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

UM School of Medicine Center for Celiac Research finds rate of celiac disease is growing

September 26, 2010 10:31 pm | by EurekAlert | News | Comments

(University of Maryland Medical Center) The number of celiac disease cases in the US has doubled every 15 years since 1974, increasing particularly among older people, according to a new study from the University of Maryland School of Medicine's Center for Celiac Research. As people in...

TOPICS:

Genetic "Light Switches" Control Muscle Movement

September 26, 2010 8:32 pm | by Massachusetts Institute of Technology | News | Comments

The technique will improve research on neuromuscular disorders and could one day help paralyzed patients.

Hospira Receives TGA Approval for Nivestim™, Australia's First Biosimilar Filgrastim

September 26, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, Sept. 26 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration (TGA) approval for its biosimilar filgrastim product, Nivestim™. Nivestim has been...

TOPICS:
Advertisement

Genetic ancestry: A new look at racial disparities in head and neck cancer

September 26, 2010 9:36 am | by EurekAlert | News | Comments

(Henry Ford Health System) Head and neck cancer outcomes associated with race may be more closely linked to social and behavioral factors than biological differences, especially for African-Americans, according to a new Henry Ford Hospital study. Researchers found that while those...

TOPICS:

Stress can control our genes

September 26, 2010 5:34 am | by EurekAlert | News | Comments

(University of Copenhagen) Researchers from Dr. Klaus Hansen's laboratory at BRIC, University of Copenhagen, have just shown that stress-factors can control our genes: Exposing human cells to a stress-activating compound turned on genes that are normally silenced. Protective...

TOPICS:

2010 AAO-HNSF new research daily highlights: Sunday, Sept. 26, 2010

September 26, 2010 5:34 am | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Featuring more than 305 scientific research sessions, 594 posters and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover...

TOPICS:

Invensense IPO will change the competition in the motion sensing business

September 25, 2010 11:33 am | by I-Micronews | News | Comments

Business is there: moving from $300M in 2009 to $1.2B in 2015 only for smart phones

Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

DULUTH, Minn., Sept. 25 /- CSL Plasma , one of the world's largest collectors of human plasma, is honoring donors from the Duluth area today as part of a statewide observance of "Plasma Protein Therapies Month." According to Randy Furby, Senior Vice President and General Manager of CSL...

TOPICS:
Advertisement

HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Sept. 25 /- Boston Scientific Corporation (NYSE: BSX ) today announced three-year follow-up data from the HORIZONS-AMI trial.  The trial, sponsored by the Cardiovascular Research Foundation (CRF) with grant support from Boston Scientific and The Medicines Company...

TOPICS:

Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT ...

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 25 /- OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell (EPC) capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture...

TOPICS:

HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients

September 25, 2010 9:31 am | by Boston Scientific | News | Comments

NATICK, Mass., Sept. 25 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced three-year follow-up data from the HORIZONS-AMI trial.  The trial, sponsored by the Cardiovascular Research Foundation (CRF) wi

TOPICS:

Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardi...

September 25, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Sept. 25 /- Today Astellas Pharma US, Inc. ("Astellas") announced results of a Phase IV study showing Lexiscan® (regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or...

TOPICS:

Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials

September 24, 2010 4:33 pm | by U.S. Food & Drug Administration | News | Comments

Recall due to risks of embolic, thrombotic and other vascular serious adverse events.

AACR Applauds Appointment of Ellen V. Sigal, Ph.D., to the Patient-Centered Outcomes Research Institute Board of Governors

September 24, 2010 3:33 pm | by AACR | News | Comments

WASHINGTON, D.C. — The American Association for Cancer Research applauds the appointment of Ellen V. Sigal, Ph.D., chairperson and founder of the Friends of Cancer Research, to the board of governors for the new Patient-Centered Outcomes Research Institute (PCORI).

TOPICS:

AACR President-elect Testifies Before President’s Cancer Panel

September 24, 2010 3:31 pm | by AACR | News | Comments

WASHINGTON, D.C. — AACR President-elect Judy E. Garber, M.D., M.P.H., testified on Sept. 22 before the President's Cancer Panel, "The Future of Cancer Research: Accelerating Scientific Innovation." The panel is exploring progress achieved since the National Cancer Act of 1971, and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading